Amyvid™ (Florbetapir F 18 Injection) Recommended for Approval in Europe as a Diagnostic Tool for PET Imaging of Beta-Amyloid Plaque Density
Read more here
News
BioAdvance Expands Team to Support Portfolio Companies and New Investments
Read more here
Galleon Pharmaceuticals Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression
Read more here
Philly Inc: Small Businesses Solving Big Problems
Read more here
Novira Therapeutics raises $23M
Read more here
FDA Accepts NuPathe Inc. (PATH)’s Migraine Patch NDA Resubmission for Filing
Read more here
QR Pharma Announces the Start of a Phase I Clinical Study for Bisnorcymserine
Read more here
QR Pharma Announces Publication on Posiphen Clincial Trials Showing Promise
Read more here
TREVENTIS Corporation Scientific Founder, Named Sobey Chair in Alzheimer’s Disease Research
Read more here
Ceptaris Secures $10 Million in Series D-1 Financing
Read more here